CNSX:CURE

Direxion Daily Healthcare Bull 3X Shares (CURE) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
44,500 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Direxion Daily Healthcare Bull 3X Shares

Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It also engages in the research and development of CAR T Cell therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and hair growth products. Biocure Technology Inc. was founded in 2005 and is headquartered in Vancouver, Canada.

CURE Stock News Headlines

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Markets Rise To Start The Trading Week
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Adding Some Juice to the Healthcare Trade
See More Headlines
Receive CURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily Healthcare Bull 3X Shares and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Björn Cochlovius Ph.D.
    President
  • Mr. Konstantin Lichtenwald B.B.A. (Age 40)
    C.P.A., CGA, CFO, Corporate Secretary & Director
    Comp: $60k
  • Mr. Yee Sing Cheng (Age 43)
    CEO & Director
  • Mr. Marco Nonni
    Consultant

CURE Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Direxion Daily Healthcare Bull 3X Shares own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily Healthcare Bull 3X Shares investors own include NVIDIA (nvda), Advanced Micro Devices (AMD), Gilead Sciences (gild), Merck & Co., Inc. (MRK), Micron Technology (MU), Spotify Technology (SPOT), Block (SQ), Tesla (TSLA), Abbott Laboratories (ABT) and AbbVie (ABBV).

How do I buy shares of Direxion Daily Healthcare Bull 3X Shares?

Shares of CURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:CURE) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners